ERYTHROMYCIN BRAND DEVIATION IN INDIA (***RECOMMENDED ACCORDING TO MCI TO WRITE THE PRESCRIPTION IN GENERIC NAME IN LEGIBLE CAPITAL LETTER WITH PROPER FORMULATION AND DOSAGE).
GENERIC NAME : ERYTHROMYCIN
"BRANDS ARE JUST A NAME NOT THE QUALITY IN CASE OF MEDICINE ".
IF THE DRUG IS PRESCRIBED IN A NEAT MANNER THAT A PHARMACIST CAN EASILY UNDERSTAND AND DELIVER THE DRUG IN APPROPRIATE TO THE PRESCRIPTION
ADVANTAGES OF GENERIC NAME PRESCRIBING:
ADVANTAGES OF GENERIC NAME PRESCRIBING:
1. UNETHICAL MARKETING WOULD BE STOPPED.
2. CORRECT DOSE TO THE PATIENT WOULD BE GIVEN .
3. EXPIRY OF DRUGS WILL BE LESS AND WASTAGE OF DRUGS WILL BE LESS.
4. COST EFFECTIVE.
5. CORRECT TREATMENT WOULD BE PROVIDED RATHER THE UNETHICAL OFFERINGS PRESCRIPTION WRITTEN BY THE CORPORATE SOCIETY.
6.LESS CONFUSION.
7. STRONG RELATIONSHIP BETWEEN DOCTORS-PATIENT-PHARMACIST.
8. GETTING FREE TIME TO GAIN KNOWLEDGE FROM A JOURNAL WITHOUT SPENDING TIME WITH REPRESENTATIVES HEARING THE SAME LOOP EVERY WEAK OR EVERY DAY.
9. IMPROVE PATIENT COMPLIANCE .
10. PRACTICE OF WRITING RATIONAL PRESCRIPTION.
11. STOPPING THE DRUG ABUSE.
12.QUALITY BLAME WOULD BE IN THE HANDS OF PHARMACIST.
13.RECORDS OF THE DRUG WOULD BE KEPT PROPER IN THE PHARMACIST AND SAME AS IN CLINICS AND HOSPITALS NO CONFUSION OCCURS
14.PATIENT CAN BE TRACKED EASILY.
15. VISIT TO THE CONCERNED DOCTOR WILL BE REGULAR AS POSSIBLE.
16. PRICE RANGE IS FIXED WHAT EVER THE BRAND IS PRESCRIBED .
DISADVANTAGES OF GENERIC PRESCRIBING:
1.QUALITY DRUGS MUST BE SELECTED BY THE PHARMACIST IT WILL BE QUALITY .IN CASE OF HAVING A PRESCRIPTION HAVE GIVEN TO THE NON PHARMA PERSON RUINING A SHOP WOULD BE IN DANGER OF QUALITY.
2.DOCTORS WONT GET ANY OFFERS AND UNETHICAL MONEY.
3.NO FREE TRIP AS GIVEN BY MANY PHARMACEUTICAL COMPANY.
4. MANY COMPANY MAY EMERGE BECAUSE OF THIS AND MAY PRODUCE LESS QUALITY PRODUCTS (IF THE DRUG CONTROL DEPARTMENT IS STRONG ENOUGH WE CAN TRUST IT)50:50 RATIO ON THIS POINT.
5. PHARMACIES MAY ADD A BILLING OF DISPENSING FEE ON DISPENSING THE PRESCRIPTION AS THE MARGIN LEVEL WAS DOWN (PRACTICED IN UK,USA,CANADA,EUA).
BRANDS AND FORMULATION
********ONLY FOR REFERENCE PURPOSE NOT FOR MARKETING.**********
BRAND NAME | FORMULATION | MANUFACTURER | PACKAGE | MRP AS PER 2020 |
ALTHROCIN 500MG | TABLET | ALEMBIC | 10 | 43.10 |
ALTHROCIN 250MG | TABLET | ALEMBIC | 10 | 84 |
ALTHROCIN 100MG | TABLET | ALEMBIC | 10 | 17.41 |
ALTHROCIN 125 MG | TABLET | ALEMBIC | 10 | 23.35 |
ALTHROCIN 100MG | PED.DROPS | ALEMBIC | 1 | 38.80 |
ALTHROCIN 125MG/5ML | SYRUP | ALEMBIC | 10 | 45.20 |
ERYTHROCIN 100MG | TABLET | PFIZER | 10 | 16.55 |
ERYTHROCIN 250MG | TABLET | PFIZER | 10 | 37.67 |
ERYTHROCIN 500MG | TABLET | PFIZER | 10 | 80.70 |
ERYTHROCIN *** | GRANULES*** | PFIZER | NIL | 17.48 |
ERYTHROCIN 125MG/5ML | SUSPENSION | PFIZER | 1 | 20.92 |
ERYCIN 125MG | TABLET | CIPLA | 10 | 16.68 |
ERYCIN 250MG | TABLET | CIPLA | 10 | 56.40 |
ERYCIN 500MG | TABLET | CIPLA | 10 | 42.50 |
ERYCIN TOPICAL GEL | GEL | CIPLA | 1 | 44.76 |
ERYCIN 125MG | SYRUP | CIPLA | 1 | 32 |
ETOCIN 250 MG | TABLET | CADILA | 10 | 600 |
ERYSAFE 250MG | TABLET | USV | 10 | 40 |
EMTROCIN 250MG | TABLET | ABBOTT | 10 | 33.08 |
EMTROCIN 125/5ML | SUSPENSION | ABBOTT | 1 | 24.99 |
ERYTHRO 250MG | TABLET | OMEGA PAHRMACEUTICALS | 10 | 54.56 |
ERYTHRO 500MG | TABLET | OMEGA PHARMACEUTICALS | 10 | 99.98 |
tablet | syrup | drops | topical and micellaneus |
TAB | SYRUP | PEDATRIC DROPS | NOT FOR INDIA***/NOT RELAVENT FORMULATION |
BY
ANANDA PHARMACY.
TAMILNADU,INDIA
Comments
Post a Comment